Cardinal Health

Cardinal Health is an integrated healthcare services and products company based in Dublin, Ohio, operating since 1971. It serves a diverse range of healthcare providers, including hospitals, pharmacies, and clinical laboratories, with a focus on enhancing cost-effectiveness and efficiency in patient care. The company operates through two main segments: Pharmaceutical and Medical. The Pharmaceutical segment encompasses the distribution of branded and generic pharmaceuticals, specialty drugs, and over-the-counter products, alongside services such as medication therapy management and pharmacy management for hospitals. The Medical segment manufactures and distributes a wide variety of medical, surgical, and laboratory products, including incontinence and wound care items, as well as surgical supplies. Cardinal Health also engages in supply chain management and consulting services for healthcare providers, ensuring a comprehensive approach to healthcare delivery. With a workforce of over 30,000 employees, Cardinal Health emphasizes improving healthcare quality and safety while supporting profitability for its clients.

Kim Farmer

Director Network Services

54 past transactions

Bendcare Management Services Organization

Corporate Round in 2022
Bendcare Management Services Organization provides management services.

Medically Home

Venture Round in 2022
Medically Home Group, Inc., based in Boston, Massachusetts, offers a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on providing patient-centered care for individuals with serious or complex illnesses, including conditions such as heart failure, pneumonia, urinary tract infections, cellulitis, and respiratory issues. Medically Home's innovative model enables the safe transition of medical care from traditional hospital settings to patients' homes, allowing for centralized, on-demand management of acute medical needs. This approach connects patients with caregivers while facilitating monitoring and communication, ensuring that patients and their families receive comprehensive support in a familiar environment.

Vineti

Series C in 2020
Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies. The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatment of late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine. Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016.

Vineti

Series C in 2020
Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies. The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatment of late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine. Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016.

Medically Home

Series B in 2019
Medically Home Group, Inc., based in Boston, Massachusetts, offers a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on providing patient-centered care for individuals with serious or complex illnesses, including conditions such as heart failure, pneumonia, urinary tract infections, cellulitis, and respiratory issues. Medically Home's innovative model enables the safe transition of medical care from traditional hospital settings to patients' homes, allowing for centralized, on-demand management of acute medical needs. This approach connects patients with caregivers while facilitating monitoring and communication, ensuring that patients and their families receive comprehensive support in a familiar environment.

Mscripts

Acquisition in 2019
Mscripts, LLC specializes in developing mobile-based pharmacy solutions through a Software as a Service (SaaS) model. Founded in 2008 and headquartered in San Francisco, the company provides an online pharmacy transaction processing platform that connects mobile customers with pharmacy and prescription systems. This platform allows customers to manage their prescriptions, receive notifications, and communicate with their pharmacy via a two-way text messaging service. Mscripts aims to enhance patient engagement and adherence by delivering targeted messages and health information through mobile devices. In addition to its core services, the company also offers implementation, integration, customization, and customer support. As of 2019, Mscripts operates as a subsidiary of Cardinal Health, Inc.

Mirixa

Acquisition in 2019
Mirixa Corporation specializes in technology-enabled solutions for medication therapy management (MTM) services. Based in Reston, Virginia, the company provides MirixaPro, a web-based clinical platform that supports standardized patient care services and allows pharmacies to develop their own patient care programs. This platform includes templates for chronic disease management and enhanced documentation capabilities. Mirixa also offers productivity tools, resources for pharmacies, and an academic partnership program that connects colleges of pharmacy with educational opportunities to improve patient care. Additionally, the company manages pharmacy-delivered programs for health plans, such as formulary management and disease-specific coaching, and develops direct-to-patient medication management programs for pharmaceutical and biotech clients. Mirixa's technology is utilized by pharmacy benefit managers, health plans, and employers to implement standardized programs across various healthcare settings. Founded in 2006, the company was previously known as Community MTM Services, Inc. before rebranding in 2007.

NaviHealth

Venture Round in 2018
naviHealth, Inc. specializes in providing and managing post-acute healthcare services in the United States. The company partners with health plans, hospitals, and post-acute care providers to manage the entire continuum of post-acute care. It develops post-acute care management software and offers clinical support services that include care coordination and data analysis to enhance patient outcomes. By utilizing evidence-based protocols and technology-enabled services, naviHealth aims to optimize care plans, reduce hospital readmissions, and increase patient satisfaction. The company employs proprietary tools to deliver customized, patient-centric care plans and develops strategic insights to improve workflows and provider relationships. Founded in 2011 and headquartered in Brentwood, Tennessee, naviHealth also has offices in Newton, Massachusetts, and Conshohocken, Pennsylvania. As of May 2020, it operates as a subsidiary of OptumHealth, Inc.

Medtronic - Patient Monitoring & Recovery

Acquisition in 2017
Medtronic - Patient Monitoring & Recovery Division is a deep vein thrombosis and nutritional insufficiency businesses.

TelePharm

Acquisition in 2016
TelePharm is a digital healthcare company helping revolutionize the way pharmacies connect with their patients. Our solutions expand the reach of how a pharmacist can practice resulting in patient focused pharmacy care while increasing productivity. Our solutions are simple, well designed and easy to use and our cloud based platform fits into any existing workflow.

RainTree Oncology Services

Acquisition in 2016
RainTree Oncology Services specializes in oral drug acquisition and management, aiming to enhance the quality of care for cancer patients. The company supports community oncology practices by expanding their services and improving patient outcomes. It also focuses on strengthening the economic viability of these practices. Additionally, RainTree is dedicated to creating an integrated information network that connects physicians, payers, and manufacturers, thereby advancing the field of oral oncology. With a commitment to being physician-centric and patient-focused, RainTree Oncology Services prioritizes the needs of the community it serves.

Aver Inc.

Series B in 2016
Aver Inc. is a health information technology company based in Columbus, Ohio, founded in 2010. The company specializes in software that facilitates the creation and management of healthcare payment bundles. Its key offerings include the avercloud platform, which integrates payers, providers, and patients into a cohesive value-based payment solution. Additionally, Aver provides Formulary, a service for publishing and commercializing proprietary algorithms, and Converge, which allows users to input diverse data formats from various sources. These solutions assist healthcare organizations in transforming their operations by enhancing bundling design, analytics, network configuration, patient risk scoring, quality assessment, performance metrics, and gainsharing administration. Aver Inc. was previously known as Aver Informatics, Inc. before rebranding in June 2015.

NaviHealth

Acquisition in 2015
naviHealth, Inc. specializes in providing and managing post-acute healthcare services in the United States. The company partners with health plans, hospitals, and post-acute care providers to manage the entire continuum of post-acute care. It develops post-acute care management software and offers clinical support services that include care coordination and data analysis to enhance patient outcomes. By utilizing evidence-based protocols and technology-enabled services, naviHealth aims to optimize care plans, reduce hospital readmissions, and increase patient satisfaction. The company employs proprietary tools to deliver customized, patient-centric care plans and develops strategic insights to improve workflows and provider relationships. Founded in 2011 and headquartered in Brentwood, Tennessee, naviHealth also has offices in Newton, Massachusetts, and Conshohocken, Pennsylvania. As of May 2020, it operates as a subsidiary of OptumHealth, Inc.

Outcomes Incorporated

Acquisition in 2015
OutcomesMTM is the national leader in the design, delivery and administration of Medication Therapy Management programs. The company's service line benefits health care purchasers by delivering a cost-effective approach to advancing patient care and controlling utilization through the provision of patient-friendly, face-to-face Personal Pharmacist™ services.

The Harvard Drug Group

Acquisition in 2015
The Harvard Drug Group is a prominent supplier of prescription and over-the-counter (OTC) medications, as well as vitamins, with a rich history that began as a family business nearly fifty years ago. Through strategic acquisitions, it has grown into one of the largest providers in the United States, offering a diverse portfolio of affordable and safe branded and generic products. The company is dedicated to supporting healthcare providers in a competitive market, ensuring they have access to high-quality pharmaceuticals. Emphasizing customer service and integrating core principles such as integrity and responsibility, The Harvard Drug Group aims to be an essential partner for both pharmaceutical manufacturers and healthcare providers, driving value and growth in the pharmaceutical care sector.

Cordis

Acquisition in 2015
Cordis Corporation, a subsidiary of Johnson & Johnson, is a leading developer and manufacturer of interventional vascular medical devices based in Miami Lakes, Florida. The company specializes in creating minimally invasive cardiovascular technologies, including drug-eluting stents, catheters, guidewires, and vena cava filters, which are essential for treating coronary and peripheral vascular diseases. Cordis's innovative products are designed to improve patient care while helping healthcare providers reduce costs and enhance operational efficiency. Through its advanced technological solutions and a strong understanding of the medical market, Cordis has established itself at the forefront of interventional medicine and minimally invasive medical procedures.

Emerge Medical

Acquisition in 2014
Emerge Medical, based in Denver, Colorado, specializes in the development, manufacturing, and distribution of orthopedic surgical devices and trauma products. The company offers a range of products, including plates, screws, total joint products, and guide wires, primarily aimed at hospitals and healthcare institutions. Emerge Medical is committed to reducing costs within the healthcare system, achieving cost savings of 40-60% for hospitals by streamlining the traditionally expensive processes associated with the medical device industry. This focus on cost efficiency positions Emerge Medical as a significant player in the orthopedic device market.

Access Closure

Acquisition in 2014
Access Closure, Inc. is a medical device company based in Mountain View, California, specializing in access site management products that facilitate vascular closure during interventional and diagnostic procedures. Founded in 2002, the company is known for its Mynx delivery system, a vascular closure device that employs a water-soluble, extravascular sealant. This innovative sealant expands within the tissue tract by absorbing blood and subcutaneous fluids, effectively sealing the arteriotomy. Access Closure aims to simplify the complex challenges associated with vascular closure, thereby enhancing patient outcomes during medical procedures.

KEW

Venture Round in 2014
KEW, Inc. is a genomic testing company focused on personalized cancer treatment. Based in Cambridge, Massachusetts, it offers a range of services that assist oncologists in making informed treatment decisions based on the genetic characteristics of individual tumors. KEW utilizes its proprietary CANCERPLEX testing service, which includes various panel options such as CANCERPLEX FP for full genomic analysis, CANCERPLEX TS for specific tumor types, and CANCERPLEX TX for FDA-approved targeted therapies. By providing these genomic insights, KEW aims to enhance the precision of oncology care, enabling healthcare providers to deliver tailored therapies that align with each patient's unique genetic profile. The company was founded in 2009 and has evolved to support community oncology practices in optimizing patient care through advanced genomic information.

Wavemark

Acquisition in 2013
WaveMark, Inc. provides information products that enable hospitals and manufacturers to control and manage the flow of consumable medical devices. Its product enables to capture, store, and provide data via Web browser for manufacturers and hospitals. The company uses radio frequency identification technology to collect and report real time information in a hands free environment. WaveMark, Inc. was founded in 2003 and is based in Littleton, Massachusetts

HealthSpot

Venture Round in 2013
HealthSpot mission is to increase access to high quality, convenient and affordable healthcare services. We do this with the innovative application of technology to healthcare. Our telemedicine Care4 Station is the ultimate access point to better healthcare, using our powerful custom software platform to bring together patients and providers in convenient neighborhood locations. We have the tools to empower healthcare professionals, making healthcare smarter, simpler and more accessible for everyone. HealthSpot files for bankruptcy on Jan, 2016.

AssuraMed

Acquisition in 2013
AssuraMed is a direct-to-customer provider specializing in disposable medical products for patients with chronic diseases. The company operates through two primary segments: Independence Medical and Edgepark Medical Supplies. Independence Medical acts as an outsourced supply chain for over 12,000 commercial customers, including durable medical equipment suppliers, independent pharmacies, and wholesale distributors. Edgepark collaborates directly with over 600 managed care organizations to deliver medical supplies to patients' homes, offering services that enhance utilization, billing efficiencies, and patient compliance. AssuraMed's product range includes supplies for ostomy care, diabetes management, urological issues, incontinence, respiratory care, and wound care, catering to managed care beneficiaries, home care supply providers, and healthcare professionals.

MCD

Acquisition in 2012
MCD is a company that was acquired by Cardinal Health in 2012.

Dik Drug

Acquisition in 2012
Dik Drug is a company that was acquired by Cardinal Health in 2012.

Zuellig Pharma

Acquisition in 2010
Zuellig Pharma has been successfully serving the Asia healthcare market since 1922; during this time our network has expanded to cover the needs of 13 countries and regions. We consistently strive to deliver relevant tailored solutions, coupled with critical market insights, to enable our healthcare partners to best connect with and realize the full market potential of the fast-growing dynamic Asian markets.

Kinray

Acquisition in 2010
Kinray is a distributor specializing in pharmaceutical and healthcare products, including generics, health and beauty aids, home health care items, vitamins, and medical candies. The company has established a strong reputation for providing dependable service to independent pharmacy customers. As a full-service wholesaler, Kinray focuses on delivering timely and courteous support to ensure customer satisfaction. With a commitment to quality and reliability, Kinray continues to be a trusted partner in the healthcare distribution sector.

HLS Freight Services

Acquisition in 2010
HLS Freight Services is a company that was acquired by Cardinal Health in 2010.

Healthcare Solutions Holding

Acquisition in 2010
Provides health care management solutions that help patients' health care outcomes and in the delivery of health care services.
Borschow Hospital & Medical Supplies is the largest distributor of pharmaceutical products and medical supplies in Puerto Rico.

Enturia

Acquisition in 2008
ChloraPrep® brand products are used widely in U.S. hospitals and surgery centers to disinfect the skin before surgical and vascular procedures to help prevent blood stream and surgical site infections, two of the most common types of health care-associated infections (HAIs) among patients.

Viasys Healthcare

Acquisition in 2007
Viasys Healthcare is a healthcare company headquartered in Geispolsheim-Gare, France, that specializes in respiratory, neuro-care, and medical/surgical technologies. Founded in 1995 by Douglas DeVries and Randy Thurman, Viasys Healthcare manufactures and distributes a range of medical products and instruments. Its offerings include respiratory and neurology products, medical disposables, sleep therapy devices, and orthopedic solutions, all designed to diagnose various disorders, including neurological, auditory, and cardiovascular conditions. The company aims to enhance healthcare safety while providing immediate revenue opportunities through its research-based medical technology solutions.

CareFusion

Acquisition in 2006
CareFusion Corporation (CareFusion) is a global medical technology company. The Company operates in two segments: Medical Systems and Procedural Solutions. The Medical Systems segment is organized around its medical equipment businesses. The Company’s Medical Systems segment’s business units and product lines include Infusion Systems, Dispensing Technologies, and Respiratory Technologies. The Procedural Solutions segment is organized around the Company’s disposable products and reusable surgical instruments businesses. The Company’s Procedural Solutions segment’s business units and product lines include Infection Prevention, Medical Specialties and Specialty Disposables. In August 2011, the Company acquired Rowa. In June 2012, the Company acquired U.K. Medical Limited. In July 2012, Natus Medical, Inc. acquired the Nicolet neurodiagnostic business from CareFusion.

MedMined

Acquisition in 2006
MedMined, Inc. provides data mining analysis and related technical, clinical, and financial consulting services to the healthcare community.

ParMed Pharmaceuticals

Acquisition in 2006
ParMed is your source for the highest quality pharmaceuticals, competitive pricing and superior service for the past 47 years - one of the longest in the industry!

Nitric Bio

Series A in 2006
NitricBio is a mid-stage specialty pharmaceutical company focused on the dermatology and podiatry markets, with two unique drug delivery technologies. The first technology involves the development and commercialization of topical nitric oxide gas. Nitric oxide has both direct and regulatory actions with known anti-infective and anti-inflammatory properties. The company's current focus is on the development of a treatment for moderate-to-severe tinea pedis (athlete's foot), which is currently in late Phase 2 clinical trials.

Geodax Technology

Acquisition in 2004
Geodax Technology is a Pharmaceuticals company.

Alaris Medical Systems

Acquisition in 2004
ALARIS Medical Systems ( www.alarismed.com ) develops and markets products for the safe delivery of intravenous (IV) medications. The Company's IV medication and infusion therapy delivery systems, software applications, needle-free disposables and related monitoring equipment are marketed in the United States and internationally. ALARIS' "smart" pumps, with the proprietary Guardrails(R) Safety Software, help to reduce the risks and costs of medication errors, help to safeguard patients and clinicians and gather and record clinical information for review, analysis and interpretation. The Company provides its products, professional and technical support and training services to over 5,000 hospital and health care systems, as well as alternative care sites, in more than 120 countries through its direct sales force and distributors.

Gala Biotech

Acquisition in 2003
Gala Biotech, a Catalent Pharma Solutions Company, was established in 1996 from technology developed at the University of Wisconsin. Located in Middleton, Wisconsin, this rapidly growing company (currently over 40 employees, including 16 PhD’s) has a wide range of capabilities in the fields of molecular biology, vector biology, cell line development, biopharmaceutical manufacturing, protein biochemistry, and quality systems. Gala’s core proprietary technology is GPEx® (Gene Product Expression), a gene insertion/expression technology that allows rapid creation of stable, high-expressing mammalian cell lines for a wide variety of gene products. "Gala" is Greek for milk, and the company's original mission was to produce pharmaceutical proteins in the milk of transgenic cows. The gene insertion technology that Gala developed to generate transgenic animals became the basis of Gala's Gene Product Expression or GPEx® technology for production of recombinant proteins in mammalian cell culture. The genomics revolution has led to the identification of thousands of new genes, and the race is now on to discover, characterize and stably express the protein products of these genes in order to develop new therapeutic proteins. Gala's GPEx® technology, when applied to mammalian cell culture, accelerates this process for its biopharmaceutical partners. Once new therapeutic proteins have been identified for clinical development, production support becomes a major challenge. Gala's mission is to meet this need, and the company has recently established a 43,000 square-foot facility in Middleton, Wisconsin devoted to GPEx®-based cell line development and cGMP-compliant protein production.

Syncor

Acquisition in 2002
Syncor International Corporation specializes in high technology healthcare services, focusing on nuclear pharmacy, medical imaging, niche manufacturing, and radiotherapy. In nuclear pharmacy, Syncor compounds and dispenses radiopharmaceuticals for both diagnostic and therapeutic applications, serving over 7,000 customers across the United States via an extensive network of 130 domestic and 19 international pharmacies. The company also provides medical imaging services through 72 domestic and 19 international facilities, managed by its subsidiary, Comprehensive Medical Imaging, Inc. Additionally, Syncor operates eight domestic and two international production sites for positron emission tomography (PET) radiopharmaceuticals and engages in agreements to enhance the accessibility of PET technology for healthcare providers and patients nationwide.

Boron, LePore & Associates

Acquisition in 2002
Boron LePore & Associates, Inc., provides integrated medical education to the health care industry. The company's services include strategic consultation, content development, accredited and non-accredited program development and execution, logistics management and a variety of internet-based solutions related to these services.

Magellan Laboratories

Acquisition in 2002
Magellan develops and tests early-stage drugs for more than 200 pharmaceutical and biotechnology companies,

Bindley Western Industries

Acquisition in 2000
Bindley Western Industries is a pharmaceutical distribution and services company.

Bergen Brunswig Corp

Acquisition in 2000
Bergen Brunswig Corporation ( www.bergenbrunswig.com ) is a supplier of pharmaceuticals, medical- surgical supplies and specialty health-care products as well as information management solutions and consulting services.

Esurg.com

Series B in 2000
Esurg.com, the most comprehensive and trusted online source for medical, surgical and pharmaceutical supplies and information. They designed Their Web site for the growing number of physician practices and clinics working outside traditional hospital settings — to give them an edge in the increasingly complex business of medicine.

WiseBear.com

Series A in 2000
WiseBear.com is an e-commerce platform and online community focused on helping people lead a more balanced life. The company was founded in 1999 and is based in New York, United States.

Automatic Liquid Packaging

Acquisition in 1999
Automatic Liquid Packaging is a manufacturer of sterile liquid pharmaceuticals and other health-care products in topical, oral, inhaled and ophthalmic formulations.

Owen Healthcare

Acquisition in 1996
A provider of outsourced management services for hospital pharmacies and materials management departments.

PCI Pharma Services

Acquisition in 1996
PCI are an integrated full service provider and a trusted partner to leading companies in the global healthcare industry. It offers unparalleled expertise and experience in taking compounds from the earliest stages of development through to commercial launch, delivering speed to market and commercial success for their customers.

Pyxis Corporation

Acquisition in 1996
Pyxis offers a range of behavioral health services for its customers. Its services include pro-social skills acquisition, psychosocial rehabilitation, life skills training, tutoring, mentoring, parent support and coaching, family mentoring, attendant care, respite care, intensive in-home, crisis intervention, and support services. It facilitates behavioral aide, after school group support, and day camps. Pyxis was acquired by Cardinal Health in February 1996. Pyxis Corporation was founded in 1994.

Medicine Shoppe International

Acquisition in 1995
Medicine Shoppe International operates a pharmacy chain established in 1968 by St. Louis pharmacist Michael Busch. The company is dedicated to providing personalized service through pharmacist-managed operations, allowing for a focus on customer needs. Medicine Shoppe pharmacies cater to a wide range of health conditions, offering medications for diseases such as cancer, Alzheimer's, depression, congestive heart failure, asthma, osteoarthritis, and anxiety disorders. The business model has demonstrated success by prioritizing both customer care and operational efficiency, making it a notable presence in the United States pharmacy landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.